Result of AGM Archives - Advanced Medical Solutions https://admedsol.com/message-type/result-of-agm/ Mon, 30 Jun 2025 13:19:53 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://admedsol.com/wp-content/uploads/2026/02/cropped-Web-Icon-32x32.png Result of AGM Archives - Advanced Medical Solutions https://admedsol.com/message-type/result-of-agm/ 32 32 Results of Annual General Meeting https://admedsol.com/regulatory-news-announcements/7729728/ Mon, 30 Jun 2025 13:29:36 +0000 https://admedsol1stg.wpenginepowered.com/?post_type=rns-post&p=9008 RNS Number : 0203P Advanced Medical Solutions Grp PLC 30 June 2025 30 June 2025   Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Results of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General Meeting […]

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>

RNS Number : 0203P
Advanced Medical Solutions Grp PLC
30 June 2025

30 June 2025

 

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Results of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 3 June 2025.

 

The poll results were as follows.

 

Resolution

Title

For

For %

Against

Against %

Total Votes

% Issued Capital

1

FINANCIAL STATEMENTS

135,778,231

100%

3,706

0.00%

135,781,937

61.93%

2

REMUNERATION REPORT

133,782,863

98.47%

2,082,282

1.53%

135,865,145

61.97%

3

AUDITOR REMUNERATION

134,051,574

98.61%

1,891,541

1.39%

135,943,115

62.01%

4

RE-ELECT G COOK

126,950,171

93.38%

8,992,839

6.62%

135,943,010

62.01%

5

RE-ELECT D LE FORT

128,280,815

94.36%

7,662,195

5.64%

135,943,010

62.01%

6

ELECT S SEARLE

135,889,875

99.96%

53,135

0.04%

135,943,010

62.01%

7

RE-ELECT C MEREDITH

134,405,209

98.87%

1,537,801

1.13%

135,943,010

62.01%

8

RE-ELECT E JOHNSON

133,759,281

98.39%

2,183,729

1.61%

135,943,010

62.01%

9

FINAL DIVIDEND

135,944,832

100%

1,706

0.00%

135,946,538

62.01%

10

ALLOT SHARES*

135,266,755

99.50%

679,783

0.50%

135,946,538

62.01%

11

PRE-EMPTION RIGHTS*

134,287,332

98.78%

1,658,642

1.22%

135,945,974

62.01%

12

PURCHASE SHARES*

134,630,774

99.98%

27,900

0.02%

134,658,674

61.42%

*  Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 26 June = 219,243,007 shares. 62.01% of the voting capital was instructed.

 

 

 

 

 

 

 

 

 

 

– End –

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

 

 

 

 

ICR Healthcare

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Lucy Featherstone

AMS@icrhealthcare.com

 

 

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

 

 

Berenberg (Joint Broker)    

Tel: +44 (0)20 3207 7800

Toby Flaux / Detlir Elezi / Yasmina Benchekroun

 

 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters Surgical, Ifabond, Vitalitec and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made seven acquisitions: Sealantis, an Israeli developer of innovative internal sealants, Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business, Connexicon, an Irish tissue adhesives specialist, Syntacoll, a German specialist in collagen-based absorbable surgical implants and Peters Surgical, a global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices.

 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, Austria, France, Poland, Benelux, India, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 1,600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSDIFESEISEEM

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Results of Annual General Meeting https://admedsol.com/regulatory-news-announcements/4696102/ Wed, 12 Jun 2024 13:47:59 +0000 https://admedsol1stg.wpenginepowered.com/regulatory-news-announcements/4696102-2/ RNS Number : 1866S Advanced Medical Solutions Grp PLC 12 June 2024   12 June 2024   Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Results of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General […]

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>

RNS Number : 1866S
Advanced Medical Solutions Grp PLC
12 June 2024
 

12 June 2024

 

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Results of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 13 May 2024.

 

The poll results were as follows.

 

Resolution

Title

For

For %

Against

Against %

Total Votes

% Issued Capital

1

FINANCIAL STATEMENTS

         136,356,167

99.99%

                   9,361

0.01%

       136,365,528

62.69%

2

REMUNERATION REPORT

         134,014,363

98.45%

             2,107,730

1.55%

       136,122,093

62.58%

3

AUDITOR REMUNERATION

         133,257,997

97.65%

             3,210,036

2.35%

       136,468,033

62.74%

4

RE-ELECT L SHANAHAN

         129,648,691

95.22%

             6,506,705

4.78%

       136,155,396

62.60%

5

RE-ELECT G COOK

         129,863,105

95.16%

             6,601,163

4.84%

       136,464,268

62.74%

6

RE-ELECT D LE FORT

         130,840,531

95.88%

             5,623,737

4.12%

       136,464,268

62.74%

7

RE-ELECT C MEREDITH

         132,798,078

97.31%

             3,666,187

2.69%

       136,464,265

62.74%

8

RE-ELECT E JOHNSON

         136,218,616

99.82%

                245,652

0.18%

       136,464,268

62.74%

9

FINAL DIVIDEND

         136,505,565

100.00%

                      516

0.00%

       136,506,081

62.76%

10

Deferred Bonus Plan

         136,377,375

99.92%

                113,837

0.08%

       136,491,212

62.75%

11

Long Term Incentive Plan

         135,984,889

99.63%

                506,310

0.37%

       136,491,199

62.75%

12

Deferred Share Bonus Plan

         136,190,086

99.78%

                300,213

0.22%

       136,490,299

62.75%

13

ALLOT SHARES*

         135,883,826

99.56%

                600,189

0.44%

       136,484,015

62.75%

14

PRE-EMPTION RIGHTS*

         134,775,458

98.75%

             1,708,671

1.25%

       136,484,129

62.75%

15

PURCHASE SHARES*

      108,148,575

99.92%

                 82,427

0.08%

       108,231,002

49.76%

*  Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 7 June = 217,508,089 shares. 62.75% of the voting capital was instructed.

 

– End –

 

 

 

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations



 

ICR Consilium

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Lucy Featherstone

AMS@icrhealthcare.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

 

 

HSBC Bank plc (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made six acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business, Connexicon, an Irish tissue adhesives specialist, and Syntacoll, a German specialist in collagen-based absorbable surgical implants.

 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 900 employees. For more information, please see  www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

RAGSFWFEEELSELM

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Results of Annual General Meeting https://admedsol.com/regulatory-news-announcements/results-of-annual-general-meeting-3/ Wed, 31 May 2023 14:08:18 +0000 https://admedsol1stg.wpenginepowered.com/investor-relations/regulatory-news-announcements/no-rid-4927/ RNS Number : 2092B Advanced Medical Solutions Grp PLC 31 May 2023   31 May 2023   Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Results of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General […]

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>

RNS Number : 2092B
Advanced Medical Solutions Grp PLC
31 May 2023
 

31 May 2023

 

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Results of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 28 April 2023.

 

The poll results were as follows.

Resolution

Title

 For

For %

Against

Against %

Total Votes

% Issued Capital

1

FINANCIAL STATEMENTS

      135,930,178

100.00%

              2,600

0.00%

      135,932,778

62.61%

2

REMUNERATION REPORT

      134,448,331

98.78%

        1,660,110

1.22%

      136,108,441

62.69%

3

AUDITOR REMUNERATION

      129,945,308

95.88%

        5,579,727

4.12%

      135,525,035

62.42%

4

RE-ELECT P ALLEN

      121,131,315

88.99%

      14,989,308

11.01%

      136,120,623

62.70%

5

RE-ELECT G COOK

      123,309,347

90.59%

      12,804,964

9.41%

      136,114,311

62.69%

6

RE-ELECT D LE FORT

      123,977,756

91.08%

      12,136,555

8.92%

      136,114,311

62.69%

7

ELECT L SHANAHAN

      136,068,717

99.97%

             45,594

0.03%

      136,114,311

62.69%

8

RE-ELECT C MEREDITH

      131,687,725

96.74%

        4,434,124

3.26%

      136,121,849

62.70%

9

RE-ELECT E JOHNSON

      133,113,126

97.80%

        3,001,185

2.20%

      136,114,311

62.69%

10

FINAL DIVIDEND

      136,127,581

100.00%

                 278

0.00%

      136,127,859

62.70%

11

ALLOT SHARES*

      135,448,934

99.52%

           654,222

0.48%

      136,103,156

62.69%

12

PRE-EMPTION RIGHTS*

      129,949,465

95.47%

        6,165,524

4.53%

      136,114,989

62.69%

13

PURCHASE SHARES*

      135,042,435

99.95%

             63,012

0.05%

      135,105,447

62.23%

 

*  Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 26 May = 217,109,419 shares. 62.63% of the voting capital was instructed.

 

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations



 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Matthew Neal / Lucy Featherstone

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Gary Clarence / David Anderson




HSBC Bank PLC (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made five acquisitions: Sealantis, an Israeli developer of innovative internal sealants; Biomatlante, a French developer and manufacturer of surgical biomaterials, Raleigh, a leading UK coater and converter of woundcare and bio-diagnostics materials, AFS Medical, an Austrian specialist surgical business and Connexicon, an Irish tissue adhesives specialist.

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Austria, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 800 employees. For more information, please see www.admedsol.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

RAGFLFIVEVILVIV

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Results of Annual General Meeting https://admedsol.com/regulatory-news-announcements/results-of-annual-general-meeting-2/ Wed, 08 Jun 2022 13:52:55 +0000 https://admedsol1stg.wpenginepowered.com/investor-relations/regulatory-news-announcements/no-rid-4785/ RNS Number : 1871O Advanced Medical Solutions Grp PLC 08 June 2022   8 June 2022   Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Results of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General […]

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>

RNS Number : 1871O
Advanced Medical Solutions Grp PLC
08 June 2022
 

8 June 2022

 

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Results of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company’s Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 29 April 2022.

 

The poll results were as follows.

 

Resolution

 

Title

For (see note 2)

Against (see note 2)

No. of shares

%

No. of shares

%

1

Receive Annual Report and Accounts

122,189,273

99.99

2,000

0.01

2

Approve the Remuneration Report

121,168,966

99.02

1,198,956

0.98

3

Re-appoint Deloitte LLP as auditors

116,797,783

95.92

4,969,411

4.08

4

Re-elect Peter Allen

103,388,287

89.10

12,651,027

10.90

5

Re-elect Grahame Cook

113,183,101

92.49

9,190,030

7.51

6

Elect Douglas Le Fort

115,464,984

99.27

844,330

0.73

7

Re-elect Chris Meredith

120,304,522

98.31

2,068,609

1.69

8

Re-elect Eddie Johnson

122,028,446

99.72

344,685

0.28

9

Declare final dividend

122,378,935

99.99

1,121

0.01

10

Authorise allotment of shares

117,948,199

96.38

4,430,807

3.62

11

Disapply pre-emption rights*

108,025,798

88.28

14,345,022

11.72

12

Authorise purchase of own shares*

94,316,659

99.05

907,369

0.95

*  Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 6 June = 216,626,583 shares. 56% of the voting capital was instructed.

 

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer



 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Matthew Cole

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Daniel Adams / Gary Clarence




HSBC Bank PLC (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. Since 2019, the Group has made four acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; Biomatlante, an established French developer and manufacturer of innovative surgical biomaterial technologies, Raleigh, a UK leading coater and converter of materials predominately for woundcare and bio-diagnostics products and AFS Medical, a specialist distributor of minimally invasive surgical devices based in Austria.

 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has more than 700 employees. For more information, please see www.admedsol.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

RAGFLFSFRDITIIF

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Results of Annual General Meeting https://admedsol.com/regulatory-news-announcements/results-of-annual-general-meeting/ Tue, 08 Jun 2021 14:24:10 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4467/ RNS Number : 2095B Advanced Medical Solutions Grp PLC 08 June 2021   Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Results of Annual General Meeting   Winsford, UK, 8 June 2021 – Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s […]

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>

RNS Number : 2095B
Advanced Medical Solutions Grp PLC
08 June 2021
 

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Results of Annual General Meeting

 

Winsford, UK, 8 June 2021 – Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual General Meeting held today at 11 am at Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 30 April 2021.

 

The poll results were as follows.

 

Resolution

 

Title

For (see note 2)

Against (see note 2)

No. of shares

%

No. of shares

%

1

Receive Annual Report and Accounts

120,604,593

99.99

330,181

0.01

2

Approve the Remuneration Report

120,394,128

99.73

5,741,835

0.27

3

Re-appoint Deloitte LLP as auditors

114,997,737

95.24

12,404,976

4.76

4

Re-elect Peter Allen

108,344,248

89.73

7,340,112

10.27

5

Re-elect Penny Freer

108,168,473

93.65

107,035

6.35

6

Elect Grahame Cook

120,642,189

99.91

596,840

0.09

7

Re-elect Chris Meredith

120,152,803

99.51

335,974

0.49

8

Re-elect Eddie Johnson

120,413,250

99.72

500

0.28

9

Declare final dividend

120,757,509

99.99

411,061

0.01

10

Authorise allotment of shares

115,674,585

99.65

12,886,611

0.35

11

Disapply pre-emption rights*

107,809,178

89.32

897,163

10.68

12

Authorise purchase of own shares*

94,716,196

99.06

330,181

0.94

*  Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 4 June = 215,650,692 shares. 56% of the voting capital was instructed.

 

– Ends –

 

 

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

 

 

 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Matthew Cole

AMS@consilium-comms.com

 

 

Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Daniel Adams / Gary Clarence / Patrick Robb

 

 

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and woundcare markets, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. In 2019, the Group made two acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; and Biomatlante, an established developer and manufacturer of innovative surgical biomaterial technologies based in France. In 2020, the Group acquired Raleigh Adhesive Coatings, a leading coater and converter of materials predominately for woundcare and bio-diagnostics products based in the UK.

 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has approximately 700 employees. For more information, please see www.admedsol.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

RAGSSFFDAEFSEEM

The post Results of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Result of Annual General Meeting https://admedsol.com/regulatory-news-announcements/result-of-annual-general-meeting/ Wed, 10 Jun 2020 11:30:06 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4154/ RNS Number : 5498P Advanced Medical Solutions Grp PLC 10 June 2020   10 June 2020 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Result of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual […]

The post Result of Annual General Meeting appeared first on Advanced Medical Solutions.

]]>
RNS Number : 5498P
Advanced Medical Solutions Grp PLC
10 June 2020
 

10 June 2020

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual General Meeting held today at 11am at the Group’s offices in Winsford, Cheshire, CW7 3RT, all resolutions were duly passed. In line with the UK Government’s latest guidelines on social distancing due to COVID-19, AMS hosted its AGM as a closed meeting, with shareholders voting in advance by proxy. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 18 May 2020.

 

Details of proxy votes received prior to the meeting will be made available on the Company’s website at www.admedsol.com. The poll results were as follows.

 

Resolution

 

For

Against

No. of shares

%

No. of shares

%

1

114,521,050

99.99

2,000

0.01

2

112,770,820

98.31

1,939,247

1.69

3

109,056,471

95.05

5,679,334

4.95

4

99,159,358

86.42

15,577,753

13.58

5

84,540,602

86.64

13,039,624

13.36

6

67,012,678

74.19

23,309,925

25.81

7

113,919,870

99.29

818,467

0.71

8

110,949,556

98.92

1,206,281

1.08

9

114,719,172

99.99

278

0.01

10

114,454,687

99.76

279,566

0.24

11*

109,047,649

95.08

5,640,944

4.92

12*

113,518,490

99.13

997,623

0.87

*Special Resolution

Notes:

1.  Votes “For” and “Against” are expressed as a percentage of votes received.

2.  A “Vote withheld” is not a vote in law and is not counted in the calculation of the votes “For” or “Against” a resolution.

3.  Total number of shares in issue at close of business on 8 June 2020 = 215,185,296 shares.  53.3% of the voting capital was instructed.

 

– Ends –

 

For further information, please contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Olivia Manser

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and woundcare markets, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, and internal fixation devices, which it markets under its brands LiquiBand®, RESORBA®, and LiquiBandFix8®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label. In 2019, the Group made two acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; and Biomatlante, an established developer and manufacturer of innovative surgical biomaterial technologies based in France.

 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, and the Czech Republic, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has approximately 700 employees. For more information, please see www.admedsol.com.

.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

RAGKKKBBKBKDFAD

The post Result of Annual General Meeting appeared first on Advanced Medical Solutions.

]]> Result of AGM https://admedsol.com/regulatory-news-announcements/result-of-agm-4/ Wed, 05 Jun 2019 17:29:54 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-3778/ RNS Number : 2905B Advanced Medical Solutions Grp PLC 05 June 2019   5 June 2019 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Result of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual […]

The post Result of AGM appeared first on Advanced Medical Solutions.

]]>
RNS Number : 2905B
Advanced Medical Solutions Grp PLC
05 June 2019
 

5 June 2019

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual General Meeting held today at 11am at the Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, all resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 30 April 2019.

 

Details of proxy votes received prior to the meeting will be made available on the Company’s website at www.admedsol.com. The poll results were as follows.

 

Resolution

 

For (see note 2)

Against (see note 2)

No. of shares

%

No. of shares

%

1

113,452,786

99.99

6,557

0.01

2

108,651,443

95.58

5,019,580

4.42

3

112,970,753

99.39

697,545

0.61

4

112,732,404

99.17

947,555

0.83

5

82,188,882

78.56

22,436,168

21.44

6

108,803,775

98.06

2,149,910

1.94

7

113,581,749

99.91

100,000

0.09

8

87,994,990

77.99

24,831,007

22.01

9

113,450,700

99.86

156,688

0.14

10*

112,116,988

98.64

1,546,482

1.36

11*

90,835,600

99.33

614,373

0.67

*Special Resolution

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand®, LiquiBand® Fix 8™, RESORBA® and ActivHeal® as well as supplying under white label.

AMS‘s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 630 employees.  For more information, please see www.admedsol.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

RAGSSWFMIFUSEEM

The post Result of AGM appeared first on Advanced Medical Solutions.

]]> Result of AGM https://admedsol.com/regulatory-news-announcements/result-of-agm-3/ Wed, 06 Jun 2018 12:15:21 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-3498/ RNS Number : 5161Q Advanced Medical Solutions Grp PLC 06 June 2018   6 June 2018 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Result of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual […]

The post Result of AGM appeared first on Advanced Medical Solutions.

]]>
RNS Number : 5161Q
Advanced Medical Solutions Grp PLC
06 June 2018
 

6 June 2018

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that at the Company’s Annual General Meeting held today at 11am at 85 Gresham Street, London, EC2V 7NQ, all Resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 26 April 2018.

 

Details of proxy votes received prior to the meeting will be made available on the Company’s website at www.admedsol.com.

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

RAGSSEFFMFASEFM

The post Result of AGM appeared first on Advanced Medical Solutions.

]]> Result of AGM https://admedsol.com/regulatory-news-announcements/result-of-agm-2/ Wed, 07 Jun 2017 11:55:14 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-3108/ RNS Number : 4256H Advanced Medical Solutions Grp PLC 07 June 2017   7 June 2017 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Result of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced […]

The post Result of AGM appeared first on Advanced Medical Solutions.

]]> RNS Number : 4256H
Advanced Medical Solutions Grp PLC
07 June 2017
 

7 June 2017

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that at the Company’s Annual General Meeting held today at 11am at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP, all Resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 8 May 2017.

 

Details of proxy votes received prior to the meeting will be made available on the Company’s website at www.admedsol.com.

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb


 

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand® and RESORBA®.

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 600 employees.  For more information, please see www.admedsol.com.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

RAGSSDFSWFWSEIM

The post Result of AGM appeared first on Advanced Medical Solutions.

]]> Result of AGM https://admedsol.com/regulatory-news-announcements/result-of-agm/ Thu, 02 Jun 2016 12:28:50 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-2805/ RNS Number : 0574A Advanced Medical Solutions Grp PLC 02 June 2016   2 June 2016 Advanced Medical Solutions Group plc (“AMS” or the “Group”)   Result of Annual General Meeting   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound […]

The post Result of AGM appeared first on Advanced Medical Solutions.

]]> RNS Number : 0574A
Advanced Medical Solutions Grp PLC
02 June 2016
 

2 June 2016

Advanced Medical Solutions Group plc

(“AMS” or the “Group”)

 

Result of Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that at the Company’s Annual General Meeting held today at 11am at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP, all Resolutions were duly passed. Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 3 May 2016.

 

Details of proxy votes received prior to the meeting will be made available on the Company’s website at www.admedsol.com.

– Ends –

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys




Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / Daniel Adams / Patrick Robb


 

 

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.
AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 510 employees.  For more information please see www.admedsol.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

RAGSSMFFEFMSEEM

The post Result of AGM appeared first on Advanced Medical Solutions.

]]>